Assay Detail
Binding
CHEMBL5374612
Review assay metadata, readout intent, target linkage, and publication context from the same page.
PROTAC activity at BRD4/VHL E3 ligase in human MCF7 cells assessed as decrease in BRD4 expression incubated for 48 hrs by Western blot analysis
1
Total Activities
1
Compounds Tested
1
Activity Types
0
Assay Parameters
Assay Information
| Assay Type | Binding |
| Organism | Homo sapiens |
| Cell Type | MCF7 |
| Confidence | 5 — Multiple protein complex / RNA |
| Curated By | Autocuration |
Target
von Hippel-Lindau disease tumor suppressor/Bromodomain-containing protein 4 (CHEMBL4296140) ↗| Type | PROTEIN-PROTEIN INTERACTION |
| Organism | Homo sapiens |
Publication
Rational Design of Bioorthogonally Activatable PROTAC for Tumor-Targeted Protein Degradation.
Activity Statistics
| Type | Count | Avg pChEMBL | Best pChEMBL |
|---|---|---|---|
| EC50 | 1 | 7.30 | 7.30 |
Compounds Tested
| Compound | Name | Phase | Activities | Best pChEMBL |
|---|---|---|---|---|
| CHEMBL5440773 | — | — | 1 | 7.30 |
Activity Data
| Compound | Name | Type | Rel. | Value | Units | pChEMBL |
|---|---|---|---|---|---|---|
| CHEMBL5440773 | — | EC50 | = | 50.32 | nM | 7.30 |